Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
ORYZON Raises €30 Million in Capital Increase
-
FEC Sponsors Meta Crypto Oasis 2025 in Dubai — A Premier Web3 Event Set to Redefine Digital Engagement
-
CG Oncology to Host Conference Call and Webcast on BOND-003 Data on Monday, April 28, 2025
-
Indicium Unveils IndiMesh, an AI-Enabled Software and Services Framework Created to Help Large Enterprises Build, Scale and Sustain AI and Data Solutions
-
Cidara Therapeutics to Report First Quarter 2025 Financial Results and Host Inaugural Quarterly Conference Call on May 8, 2025
-
Esperion Unveils Promising Research Supporting Lead Development Candidates for Primary Sclerosing Cholangitis (PSC) at R&D Day 2025
-
Relmada Therapeutics to Host KOL Event on Phase 2 NDV-01 Data
-
Snyk Achieves FedRAMP Moderate Authorization
-
Krystal Biotech to Present at Upcoming Scientific Conferences
-
BioAtla Announces Poster Presentations at the 2025 American Association for Cancer Research (AACR) Annual Meeting
-
Microchip Unveils New High-Density Power Module for AI at the Edge Applications
-
Prebid.org Debuts New Analytics Dashboard, Prebid Insights
-
ASP Isotopes Inc. Announces Proposed Secondary Listing on the Johannesburg Stock Exchange
-
Voltera Expands National Footprint with EV Charging Facilities for Light-Duty Fleets in California, Texas, Arizona, and Florida
-
Intrado Upgrades Columbus, OH 911 Services with NG911 Multimedia and AI-based Text Translation
-
Akoya Biosciences Expands Biopharma Service Portfolio with New ADC Breast Cancer Assay and Real-world IO60 Insights at AACR 2025
-
Rezolve Ai Smashes Past $50 Billion in GMV in Explosive start to 2025, Over 50 Major Enterprises Now Live and Scaling
-
Akoya Biosciences and Enable Medicine Launch the Largest Commercially Available Single-Cell Spatial Proteomics Atlas
-
TILT Sets First Quarter 2025 Conference Call for May 15 at 5:00 p.m. ET
-
CALIFORNIA BANCORP REPORTS NET INCOME OF $16.9 MILLION FOR THE FIRST QUARTER OF 2025
-
Thomas Barnes Joins Monarch Private Capital’s #Bestinclass Renewable Energy Team
-
American Oncology Network to Participate in 14 Sessions at 2025 Community Oncology Alliance Annual Conference
-
FEC Sponsors Meta Crypto Oasis 2025 in Dubai — A Premier Web3 Event Set to Redefine Digital Engagement
-
Tenneco Introduces Low Emission Brake Technology for Light and Commercial Vehicles
-
Coda Octopus Group Reports $1.4m Engineering Services Order
-
Australian Oilseeds Issues Annual Shareholder Letter
-
MISTRAS Group Launches MISTRAS Data Solutions Brand, Integrating Data-driven Capabilities for Customers Worldwide
-
Fulcrum Therapeutics to Host First Quarter 2025 Financial Results Conference Call and Webcast on Thursday, May 1, 2025, at 8:00 a.m. ET
-
Amid rising global supply chain risks, Sphera study highlights urgent need for enhanced N-Tier supply chain transparency
-
Crbon Labs and U.S. Venture Generate and Market Credits from Canadian Orphaned Gas Well
-
NevGold Discovers More Significant Oxide Gold-Antimony Results: 2.11 g/t AuEq Over 67.1 Meters (1.30 g/t Au And 0.18% Antimony), Including 4.29 g/t AuEq Over 30.5 Meters (2.79 g/t Au And 0.33% Antim
-
Performance Unlocked: AdOmni and LiveRamp Bring New Targeting and Attribution to CTV, OLV, and DOOH
-
Cronos Group Inc. to Hold 2025 First Quarter Earnings Conference Call on May 8, 2025
-
Collegium to Report First Quarter 2025 Financial Results on May 8, 2025
-
Carterra Announces its 2025 Symposia Series on Speeding Drug Discovery with AI/ML and Other New Technologies
-
Brera Holdings Portfolio Club Juve Stabia “The Second Team of Naples” Achieves Highest Market Value Increase in Serie B
-
Cocrystal Pharma’s Norovirus Oral Antiviral Candidate Demonstrates Potent Activity Against the Emerging GII.17 Variants
-
Esperion Unveils Promising Research Supporting Lead Development Candidates for Primary Sclerosing Cholangitis (PSC) at R&D Day 2025
-
NephroDI Therapeutics’ Founder and CMO Jeff M. Sands, M.D. Receives the 2025 Robert W. Berliner Award for Excellence in Renal Physiology
-
What to Do After an Accident: Miller & Jacobs Accident Attorneys Share Insights with HelloNation on Navigating Post-Crash Uncertainty
-
ZyVersa Therapeutics CEO Issues Shareholder Letter Announcing Transformative R&D Trends for Inflammasome Inhibitors, and Provides Update on Inflammasome ASC Inhibitor IC 100’s Development Status
-
Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress Washington 2025
-
Wearable Devices Unveils Revolutionary Gesture Mapper for Mudra Link, Ushering in a New Era of Personalized Neural Control
-
AKVA group ASA: Invitation to Capital Markets Day 2025
-
ZenaTech’s ZenaDrone Granted FAA Part 137 Approval for Agricultural Drone Operations Addressing a $6 Billion Global Agricultural Drone Market Growing to $24 Billion by 2032
-
CoreCard Corporation Schedules First Quarter 2025 Earnings Release and Conference Call
-
Dimensional Fund Advisors Ltd. : Form 8.3 - RENEWI PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - JOHN WOOD GROUP PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - GREENCORE GROUP PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - ENQUEST PLC - Ordinary Shares
